Spotlight Interview: Eul-Sik Yoon, M.D., Ph.D. Chairman and Board of Directors, Korean Society of Plastic and Reconstructive Surgeons, President, Korea University Anam Hospital

About Eul-Sik Yoon, M.D., Ph.D. Eul-Sik Yoon, M.D., Ph.D., is a distinguished Plastic and Reconstructive Surgeon with over 35 years of experience. Dr. Yoon is Chairman of the Korean Society of Plastic and Reconstructive Surgeons. He also serves as the President of Korea University Anam Hospital. As an influential and active

Spotlight Interview: Sharon Kleefield, Ph.D., Healthcare Standards Institute

About Sharon Kleefield, Ph.D. Retired faculty, Harvard Medical School (HMS), and former Director of Healthcare Quality at Harvard Medical International. Her work has focused on developing and deploying standards in healthcare. Her expertise includes Health Care Management Education and Training programs for clinical staff both at HMS and globally. Prior to

Spotlight Interview: Frank Amato, President and CEO, SYNAPS Dx, and Dr. Daniel Alkon, Chief Scientific Advisor, SYNAPS Dx

About Frank Amato Frank Amato is CEO and president of SYNAPS Dx. Previously, after two decades in the pharmaceutical and biotech industries, he was president, CEO and director of electroCore, a NASDAQ-traded bioelectronic medicine company focused on treating neurodegenerative conditions. Frank is an accomplished leader with a track record for consistently

Spotlight Interview: Liz Cormier-May, CEO, Mammogen, Inc.

About Elizabeth Cormier-May Liz has been in the biotechnology industry for nearly 20 years, with a focus on early start-ups and company creation.  She started her career as a medicinal chemist for Novartis Institute for Biomedical Research, working in early discovery oncology.  She quickly realized that her ability to create meaningful

Spotlight Interview: Michael Werner, Partner; Sara Klock, Associate, Holland & Knight

About Michael Werner Michael Werner is a Washington, D.C., public policy and regulatory attorney and a co-leader of Holland & Knight's Healthcare & Life Sciences Team. Mr. Werner has almost three decades of healthcare law, lobbying, regulatory and reimbursement experience in Washington. He focuses on issues affecting FDA-regulated entities, including biotechnology